SB-773812

DB16042InvestigationalSmall molecule

SB-773812 is under investigation in clinical trial NCT00259870 (SB-773812 Administered in Adults With Schizophrenia).

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 2A and Dopamine receptor D2
Curator reviewed
Formula / weight: C₂₅H₂₆ClNO₄S · 472.0 g/mol (avg)
Code names: SB-737050-A · SB-773812

Resolves to

Compound

Structure

InChIKeyHIBWHHQXUSKNOV-UHFFFAOYSA-NSMILESCOC1=C(C=C2CCN(C)CCC2=C1)S(=O)(=O)C1=CC=C(OCC2=CC=C(Cl)C=C2)C=C1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with SB-773812, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.